Adaptive immune network

The adaptive immune network is a complex, systemic biological framework responsible for providing specific, long-lasting defense against pathogens through the generation of immunological memory (Janeway et al., 2001). It is composed of specialized cells, including T lymphocytes and B lymphocytes, which utilize highly diverse receptors to recognize unique antigens presented by major histocompatibility complex (MHC) molecules (Abbas et al., 2014). In clinical contexts, the network is the primary focus of immunotherapies, where drugs are designed to either suppress overactive responses in autoimmune diseases or stimulate responses against cancer cells (Murphy & Weaver, 2016). Because it encompasses a vast array of distinct molecular entities and cellular interactions, it is classified as a biological system rather than a single therapeutic target. Consequently, pharmacological intervention typically targets specific nodes within this network, such as individual cytokines or checkpoint receptors, rather than the network in its entirety (Pardoll, 2012). The term is considered incorrect as a specific therapeutic target because it lacks the molecular specificity required for drug-target interaction profiles.

Other names

Adaptive immune systemAcquired immune systemSpecific immune system

Immunomodulation through the targeting of specific cellular components, receptors, or signaling molecules within the systemic immune framework, including checkpoint inhibition, cytokine neutralization, and lymphocyte depletion.